Total parenteral nutrition (TPN) requires the daily administration of about
38 individual components. Global costs are related to products, applicatio
n procedures to the patient, monitoring and treatments of clinical complica
tions (1-4, 7). Choosing the optimal strategy for TPN administration is ess
ential both in terms of clinical effectiveness and economic efficiency, bec
ause TPN is a relatively expensive nutrition therapy.